Though an estimated 60 million people around the world have atrial fibrillation, or A-fib, a type of irregular and often fast heartbeat, it's been at least 30 years since any new treatments have been ...

Cardiovascular disease remains a leading global health burden, yet many preclinical systems still struggle to predict how candidate drugs will perform in the human heart.

WILMINGTON, Del.--(BUSINESS WIRE)--Predicting how a person’s heart will respond to a new medicine remains one of the most persistent blind spots in drug development. Even with decades of scientific ...

Researchers at the University of Toronto's Institute of Biomedical Engineering have developed a new method to mature lab-grown heart cells, so they more closely resemble adult human heart tissue. By ...